Clicky

Atara Biotherapeutics, Inc.(ATRA) News

Date Title
Jun 21 Atara Biotherapeutics’ Ebvallo™ (tabelecleucel) Wins Prix Galien International Award for Best Product for Orphan/Rare Diseases
Jun 12 Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now
May 11 Atara Biotherapeutics First Quarter 2024 Earnings: Beats Expectations
May 9 Atara Biotherapeutics (ATRA) Reports Q1 Loss, Tops Revenue Estimates
May 9 Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress
Apr 5 Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mar 28 Atara Biotherapeutics (ATRA) Reports Q4 Loss, Tops Revenue Estimates
Mar 28 Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational Progress
Jan 11 Seth Klarman's Exit from Atara Biotherapeutics Inc
Jan 11 Seth Klarman's Firm Exits Atara Biotherapeutics Inc Holding
Dec 20 Atara Biotherapeutics Announces Closing of Expanded Global Tab-cel® Partnership with Pierre Fabre Laboratories
Nov 29 Atara Biotherapeutics To Present Positive New Tab-cel® Clinical Data During Oral Session at ESMO Immuno-Oncology Annual Congress 2023
Nov 8 Atara Biotherapeutics Announces Primary Analysis Data from Phase 2 EMBOLD Clinical Trial of ATA188 in Non-Active Progressive Multiple Sclerosis
Nov 5 Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q3 2023 Earnings Call Transcript
Nov 2 Atara Biotherapeutics Inc (ATRA) Announces Q3 2023 Financial Results and Expanded Global Partnership
Aug 8 Atara Biotherapeutics (ATRA) Reports Q2 Loss, Lags Revenue Estimates
Aug 8 Atara Biotherapeutics Announces Second Quarter 2023 Financial Results and Operational Progress
Aug 4 Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)